Monoclonal Technologies

What Monoclonal Technologies does

Monoclonal Technologies, Inc. (dba m-Tech / 4m-Tech) is a privately held diagnostic reagent manufacturer founded in 1984 by Lee Thacker, a former CDC scientist who helped develop the first Direct Fluorescent Antibody (DFA) test for Legionella during the 1976 Legionnaires' disease outbreak. The company is headquartered in Sandy Springs, Georgia, and operates as a narrow specialty provider of monoclonal and polyclonal antibodies, DFA conjugates, antigens, prepared slides, and PCR kits for the detection, serogrouping, and species identification of Legionella pneumophila and related species. Its product line includes proprietary 'all-in-one' conjugates that detect up to 14 serogroups or 19 Legionella species in a single test, plus a portfolio of Goat IgG secondary antibodies for research applications.

The company monetizes through direct unit pricing of reagents (DFA conjugates starting at $2.00/sample plus labor and materials; PCR kits and secondary antibodies sold as one-time catalog items) and laboratory confirmation testing services (priced at $20.00/sample for serogroup and strain identification on customer-submitted positive cultures). Payment terms are Net 30 with a $100 minimum order, and products are shipped overnight within the US (Monday–Thursday) while overseas orders are handled individually.

The go-to-market is sales-led and direct: the company sells to independent and public health laboratories, water treatment facilities, and research institutions through a toll-free phone line, email, and an e-commerce catalog website. Website-only marketing channels (catalogue, newsletter, downloadable product documentation) supplement the inside-sales motion, with no evidence of paid advertising, social media presence, third-party distribution, or institutional investors.

Name

Monoclonal Technologies

Legal name

Monoclonal Technologies, Inc.

Website

https://4m-tech.com

Company type

Private

Founded year

1984

Operating status

Operating

Short description

Monoclonal Technologies (m-Tech) is a privately held, 38-year-old specialty manufacturer of Legionella DFA conjugates, antigens, PCR kits, and secondary antibodies, selling direct to laboratories, water treatment facilities, and research institutions.

Ownership category

akta.pro rank

Product category

Legionella Diagnostic Reagents

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Medical Laboratories (621511)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071)

akta.pro primary industry

IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)

akta.pro secondary industries

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI), Water Sampling, Testing & Laboratory Analysis (Legionella/Microbiology) (BPABAJAB), Microbiology & Pathogen Monitoring (Legionella, Coliform, HABs) (EUAHACAI)

Keywords

• Legionella diagnostic reagents
• Monoclonal antibody production
• DFA testing conjugates
• PCR detection kits
• Waterborne pathogen testing

Headquarters

HQ city

Atlanta

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. DFA Conjugates and Antigens: Sale of Legionella DFA monospecific and panvalent conjugates, antigens, and prepared slides for Legionella pneumophila serogroup and species identification. Sold at $2.00/sample + labor and materials as add-on testing for laboratories.
2. Confirmation Testing Services: Lab confirmation services for positive cultures - identifying specific serogroup and strain for better risk reduction and remediation. Priced at $20.00/sample.
3. PCR Kits: Sale of Legionella PCR kits for Legionella pneumophila, Legionella pneumophila Serogroup 1, and Legionella spp detection.
4. Secondary Antibodies: Sale of secondary antibodies (Goat IgG) for research and product development applications including Mouse, Rabbit, Human IgG detection.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels3 records

Core offering

Monoclonal Technologies, Inc. manufactures and distributes Direct Immunofluorescence Assay (DFA) diagnostic reagents and kits for Legionella detection and identification, including monoclonal and polyclonal antibody conjugates, antigens, prepared slides, PCR kits, and secondary antibodies. The company also provides laboratory confirmation and strain identification services for positive Legionella cultures. These products and services are sold to independent and public health laboratories, water treatment facilities, and research institutions.

Product overview

Monoclonal Technologies (m-Tech) is a diagnostic products company specializing in Legionella testing solutions. The company offers a unified portfolio centered on Direct Fluorescent Antibody (DFA) conjugates and antigens, including an "all in one" conjugate capable of detecting up to 14 serogroups and a novel conjugate for 19 Legionella species (bozemanii-maceachernii). The product line spans DFA conjugates, antigens, PCR kits, prepared slides, and Goat IgG Secondary Antibodies. These products are complemented by laboratory confirmation testing services for strain identification and confirmation. The company also provides downloadable product documentation including MSDS sheets and technical protocols.

Differentiator

Problem solved

Functional benefit

Products and services

• Legionella DFA Conjugates

Quantifiable outcome

• Serogroup and strain identification for improved Legionnaires' disease risk reduction and targeted remediation
• +1 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• bioMérieux: Global in vitro diagnostics leader with a dedicated microbiology line including Legionella testing on culture and molecular platforms. Comparable as a broad incumbent whose portfolio overlaps directly with m-Tech's serogroup identification and water-testing workflow.
• Bio-Rad Laboratories: Major life science and clinical diagnostics manufacturer offering IVD reagents, antibody products, and quality controls used in clinical and research laboratories. Comparable as a broader incumbent that competes for reagent budget and antibody product sales in similar lab channels.
• MilliporeSigma (Merck KGaA Life Science): Major manufacturer and supplier of antibodies, reagents, buffers, and assay kits used in research and diagnostic laboratories. Comparable as a broad incumbent offering secondary antibodies and detection reagents that overlap with m-Tech's Goat IgG secondary antibody product line.
• IDEXX Laboratories: Established leader in water microbiology testing with Legiolert, a culture-independent method for Legionella pneumophila detection sold into commercial and industrial water testing programs. Comparable as an incumbent competing for the same Legionella monitoring budgets from a more automated, higher-throughput platform.
• Thermo Fisher Scientific (Life Sciences / Microbiology): Global life sciences tools and diagnostics supplier with broad antibody, reagent, and microbial detection products. Comparable as a broader incumbent whose antibody and microbiology reagent offerings compete with m-Tech's secondary antibody and DFA reagent catalog.

Direct peers

• Meridian Bioscience (Revvity): Diagnostics company with a long-standing Legionella test kit portfolio (EIA and immunofluorescence-based assays) sold into clinical and reference laboratories. Comparable as a developer and manufacturer of in vitro diagnostic kits including Legionella serogroup detection reagents.
• Pro-Lab Diagnostics: Microbiology-focused manufacturer of diagnostic kits, reagents, and stains for clinical and food/water laboratories. Comparable as a niche IVD reagent specialist with overlapping microbiology reagent product lines and shared customer profile of independent and public health laboratories.
• Hardy Diagnostics: Manufacturer and distributor of microbiology reagents, prepared media, and diagnostic kits including Legionella detection products. Directly comparable as a microbiology-focused IVD reagent maker serving clinical, public health, and water-testing laboratories with a similar product catalog and customer base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Monoclonal Technologies